A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single- and Multiple-Doses of JNJ-42721458 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 19 Jun 2014
At a glance
- Drugs JNJ 42721458 (Primary)
- Indications Unspecified
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Janssen Research & Development
- 19 Jun 2014 Last checked against ClinicalTrials.gov record.
- 05 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Nov 2013 New trial record